|
 |
BeclomethasoneThis page contains recent news articles, when available, and an overview of Beclomethasone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Beclomethasone (when available) Beclomethasone, a synthetic halogenated glucocorticoid with antiinflammatory and vasoconstrictive effects, is used for treating steroid-dependent asthma, allergic or nonallergic rhinitis, or recurrent nasal polyps. For the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older Mechanism Of Action: Unbound corticosteroids cross cell membranes and bind with high affinity to specific cytoplasmic receptors. The result includes inhibition of leukocyte infiltration at the site of inflammation, interference in the function of mediators of inflammatory response, suppression of humoral immune responses, and reduction in edema or scar tissue. The antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. News Articles on Beclomethasone Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM ... - Dec 28, 2009 Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment ... PR Newswire (press release) Best Evidence Review: Long-acting Beta-Agonists -- Are They Appropriate for ... - Dec 30, 2009 Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. ... Medscape Soligenix initiates Phase I/II trial for acute radiation enteritis drug - Dec 24, 2009 ...a late-stage biotechnology company, has initiated a Phase I/II clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17, ... Trading Markets (press release) Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the ... - Dec 21, 2009 Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of ... CNNMoney.com (press release) High-dose inhaled steroids for asthma may increase risk of fetal malformations - Dec 19, 2009 ...per day ICS (beclomethasone dipropionate-chlorofluorocarbone equivalent) versus 154 who took >1000 micrograms per day and 8734 who did not take ICS. ... news Stories 'í?´ë¦¬í?¼ì§€ì†?ì„±ìž¥ìš©ì •' ì•½ì œ 급여기준 ì‹ ì„¤ - Dec 21, 2009 Beclomethasone dipropionate ê²½êµ¬ì œ(품명: í?´ë¦¬í?¼ì§€ì†?성 ìž¥ìš©ì • 5mg)ì?˜ 급여기준ì?´ ì‹ ì„¤ë?œë‹¤. 보건복지가족부는 ì?´ê°™ì?€ ë‚´ìš©ì?„ í?¬í•¨í•œ ì•½ì œê¸‰ì—¬ 기준 ê°œì •ì•ˆì?„ ê³ ì‹œ ... 데일리팜 Soligenix Reports Third Quarter 2009 Financial Results - Nov 13, 2009 The granting of Orphan Drug Designation by the FDA's Office of Orphan Products Development for oral BDP (beclomethasone 17,21-dipropionate, or orBec®) for ... PR Newswire (press release) Mometasone Furoate Triumphs Over Beclomethasone Dipropionate in Patients With ... - Nov 10, 2009 ..."When compared to beclomethasone dipropionate aerosol inhaler with hydrofluoroalkane propellant patients, mometasone furoate dry powder inhaler patients ... DG News Enzon Offloads Specialty Arm to Sigma-Tau for up to $327M - Nov 9, 2009 Currently, Sigma-Tau's orBec (oral beclomethasone dipropionate) is in Phase III testing for acute graft-vs.-host disease under a partnership with Solgenix ... BioWorld Online Bullish Technical Breakout Alert (OTC:SNGX.OB) - Nov 11, 2009 Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of ... OfficialWire (press release) Teva Pharmaceutical Industries Limited Q3 2009 Earnings Call Transcript - Nov 3, 2009 The market share in NRx of 17% up from 13% in 2008 and I'm pleased to report that in October, we began Phase III trial of nasal beclomethasone dipropionate ... Seeking Alpha (blog) Asthma Control Maintained in Children Switched to Once-Daily Mometasone ... - Oct 22, 2009 ...safely controls asthma in children switched from other corticosteroid therapies, such as fluticasone propionate or beclomethasone dipropionate, ... DG News Soligenix to Present at 8th Annual BIO Investor Forum - Oct 27, 2009 Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of ... SunHerald.com (press release) Brand Names/Synonyms: Beclomethasone is also known by the following brand names and/or synonymsAerobec; Aldecin; Anceron; Andion; Beclacin; Becloforte; Beclomet; Beclometasona [Inn-Spanish]; Beclometasondipropionat Mikron; Beclometasondipropionat Mikron.; Beclometasone; Beclometasonum [Inn-Latin]; Beclomethasone; Beclorhinol; Becloval; Beclovent; Becodisks; Beconase; Beconase Aq; Beconasol; Becotide; Clenil-A; Entyderma; Inalone; Korbutone; Propaderm; Qvar; Qvar 80; Rino-Clenil; Sanasthmax; Sanasthmyl; Vancenase; Vancenase Aq; Vanceril; Vanceril Double Strength; Viarex; Viarox Drug Category: Beclomethasone is categorized under the following by the FDA: Antiarrhythmic Agents; Glucocorticoids; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA07; ATC:D07AC15; ATC:R01AD01; ATC:R03BA01 Dosage Forms: Oral inhalation; Nasal inhalation; Nasal Spray Absorption: mean peak plasma concentration was 88pg/ml at 0.5 hour Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: [9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |